(Q44699072)

English

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult

scientific article published on 29 July 2013

Statements

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult (English)
Stephen Rd Johnston
Lucy S Kilburn
Paul Ellis
David Dodwell
David Cameron
Larry Hayward
Young-Hyuck Im
Jeremy P Braybrooke
A Murray Brunt
Kwok-Leung Cheung
Rema Jyothirmayi
Anne Robinson
Duncan Wheatley
Gill Coombes
Nicole Sergenson
Hui-Jung Sin
Elizabeth Folkerd
SoFEA investigators
29 July 2013
989-998

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit